ATE70978T1 - Zusammensetzung zur erhoehung des haematokrits bei einem normalen saeugetier. - Google Patents

Zusammensetzung zur erhoehung des haematokrits bei einem normalen saeugetier.

Info

Publication number: ATE70978T1
Authority: AT; Austria
Prior art keywords: increase; mammal; haematocrit; composition; normal mammal
Prior art date: 1987-04-10

Application number

AT88303185T

Other languages

English (en)

Inventor

John F A Vance

Robert I Abels

Original Assignee

Ortho Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-04-10

Filing date

1988-04-08

Publication date

1992-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21889805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE70978(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-04-08 Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp

1992-01-15 Application granted granted Critical

1992-01-15 Publication of ATE70978T1 publication Critical patent/ATE70978T1/de

Links

241000124008 Mammalia Species 0.000 title abstract 4
238000005534 hematocrit Methods 0.000 title abstract 3
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
102000003951 Erythropoietin Human genes 0.000 abstract 3
108090000394 Erythropoietin Proteins 0.000 abstract 3
229940105423 erythropoietin Drugs 0.000 abstract 3
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 3
229910052742 iron Inorganic materials 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
230000010437 erythropoiesis Effects 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Electrotherapy Devices (AREA)
Peptides Or Proteins (AREA)

AT88303185T 1987-04-10 1988-04-08 Zusammensetzung zur erhoehung des haematokrits bei einem normalen saeugetier. ATE70978T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3664687A	1987-04-10	1987-04-10
EP88303185A EP0286439B1 (de)	1987-04-10	1988-04-08	Zusammensetzung zur Erhöhung des Hämatokrits bei einem normalen Säugetier

Publications (1)

Publication Number	Publication Date
ATE70978T1 true ATE70978T1 (de)	1992-01-15

Family

ID=21889805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88303185T ATE70978T1 (de)	1987-04-10	1988-04-08	Zusammensetzung zur erhoehung des haematokrits bei einem normalen saeugetier.

Country Status (13)

Country	Link
US (1)	US5541158A (de)
EP (1)	EP0286439B1 (de)
JP (1)	JP2858752B2 (de)
KR (1)	KR880012235A (de)
AT (1)	ATE70978T1 (de)
AU (1)	AU613905B2 (de)
DE (1)	DE3867285D1 (de)
DK (1)	DK167903B1 (de)
ES (1)	ES2035279T3 (de)
GR (1)	GR3004071T3 (de)
IE (1)	IE61008B1 (de)
NO (1)	NO881507D0 (de)
PT (1)	PT87197B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
DE19535571A1 (de) *	1995-09-14	1997-03-20	Boehringer Mannheim Gmbh	Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
ATE213638T1 (de) *	1995-12-21	2002-03-15	Smithkline Beecham Corp	Carbonyleisen-tablette durch direktverpressung
US5952226A (en) *	1996-11-05	1999-09-14	Modex Therapeutiques	Hypoxia responsive EPO producing cells
ES2180958T3 (es) *	1997-03-18	2003-02-16	Roche Diagnostics Gmbh	Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro.
US7033774B2 (en) *	1997-04-21	2006-04-25	Glycozyme, Inc.	Determination of recombinant glycosylated proteins and peptides in biological fluids
EP0885613A1 (de) *	1997-06-21	1998-12-23	Roche Diagnostics GmbH	Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
AU2591699A (en) *	1998-02-09	1999-08-23	University Of Southern California	Method of promoting erythropoiesis
US7304150B1 (en)	1998-10-23	2007-12-04	Amgen Inc.	Methods and compositions for the prevention and treatment of anemia
CN1367701A (zh) *	1999-05-11	2002-09-04	奥索－麦克尼尔药物公司	红细胞生成素给药的药代动力学和药效模型
US7459435B2 (en)	2002-08-29	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
DE10249552A1 (de)	2002-10-23	2004-05-13	Vifor (International) Ag	Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7459436B2 (en)	2002-11-22	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
DK1973549T3 (en)	2006-01-06	2016-11-21	Vifor (International) Ag	Methods and compositions for administration of the iron

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57149228A (en) *	1981-03-11	1982-09-14	Ajinomoto Co Inc	Novel erythropoietin and its preparation
US4732889A (en) *	1985-02-06	1988-03-22	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
JPS6231A (ja) *	1985-02-06	1987-01-06	Chugai Pharmaceut Co Ltd	腎性貧血治療剤
US4745099A (en) *	1985-02-06	1988-05-17	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of malignant tumors
GB2177914B (en) *	1985-06-04	1989-10-25	Chugai Pharmaceutical Co Ltd	A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US5013718A (en) *	1986-11-21	1991-05-07	Amgen, Inc.	Method for treating iron overload using EPO
JPS63227527A (ja) *	1987-03-05	1988-09-21	キリン―アムジエン（デラウエア）インコーポレーテツド	貧血予防薬

1988
- 1988-04-07 KR KR1019880003863A patent/KR880012235A/ko not_active Withdrawn
- 1988-04-07 NO NO881507A patent/NO881507D0/no unknown
- 1988-04-07 JP JP63084212A patent/JP2858752B2/ja not_active Expired - Lifetime
- 1988-04-08 EP EP88303185A patent/EP0286439B1/de not_active Expired - Lifetime
- 1988-04-08 AT AT88303185T patent/ATE70978T1/de not_active IP Right Cessation
- 1988-04-08 DK DK194288A patent/DK167903B1/da not_active IP Right Cessation
- 1988-04-08 DE DE8888303185T patent/DE3867285D1/de not_active Expired - Lifetime
- 1988-04-08 IE IE106488A patent/IE61008B1/en not_active IP Right Cessation
- 1988-04-08 AU AU14445/88A patent/AU613905B2/en not_active Expired
- 1988-04-08 ES ES88303185T patent/ES2035279T3/es not_active Expired - Lifetime
- 1988-04-08 PT PT87197A patent/PT87197B/pt not_active IP Right Cessation
1989
- 1989-09-19 US US07/409,223 patent/US5541158A/en not_active Expired - Lifetime
1992
- 1992-03-18 GR GR920400469T patent/GR3004071T3/el unknown

Also Published As

Publication number	Publication date
EP0286439B1 (de)	1992-01-02
DE3867285D1 (de)	1992-02-13
ES2035279T3 (es)	1995-04-01
NO881507D0 (no)	1988-04-07
PT87197A (pt)	1988-05-01
DK167903B1 (da)	1994-01-03
IE61008B1 (en)	1994-09-07
US5541158A (en)	1996-07-30
AU1444588A (en)	1988-10-13
JPS63277630A (ja)	1988-11-15
DK194288A (da)	1988-10-11
IE881064L (en)	1988-10-09
PT87197B (pt)	1992-07-31
DK194288D0 (da)	1988-04-08
JP2858752B2 (ja)	1999-02-17
GR3004071T3 (de)	1993-03-31
AU613905B2 (en)	1991-08-15
EP0286439A1 (de)	1988-10-12
KR880012235A (ko)	1988-11-26

Similar Documents

Publication	Publication Date	Title
ATE70978T1 (de)	1992-01-15	Zusammensetzung zur erhoehung des haematokrits bei einem normalen saeugetier.
AU562938B2 (en)	1987-06-25	7, 10, 13, 16 docosatetraenoic acid composition
AU6567086A (en)	1987-05-28	Compositions and methods for the treatment of bleeding disorders
DE68909077D1 (de)	1993-10-21	Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
SE8603582L (sv)	1988-02-27	Komposition innehallande l-dopa
IL84275A (en)	1993-04-04	Pharmaceutical composition comprising erythropoietin for treatment of iron overload disorders
IT8349596A0 (it)	1983-12-28	Preparato medicinale per la cura dell'ulcera gastroduodenale
IL86862A (en)	1993-05-13	Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna
IT1223990B (it)	1990-09-29	Procedimento per la riduzione mediante combustione dell'ossido di zolfo e dell'ossido di azoto nei combustibili ad elevato tenore di zolfo
IT1215332B (it)	1990-02-08	Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
IT1189046B (it)	1988-01-28	Perfezionamento nei procedimenti per la carburazione dell'acciaio
AU2234588A (en)	1989-03-23	Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects
IL88513A0 (en)	1989-06-30	D1-5-((2-benzyl-3',4-dihydro-2h-benzopyran-6-yl)methyl)thiazolidine-2',4-dione as an anti-atherosclerosis agent
BE891914A (fr)	1982-05-17	Sels d'acide (1-benzyl-1h-indazol-3-yl)oxy acetique avec la lysine, leur preparation et leur utilisation
IT8868103A0 (it)	1988-12-13	Procedimento per la rigenerazione di un additivo utilizzato per controllare le emissioni durante la combustione di combustibile ad elevato tenore di zolfo
IL89902A0 (en)	1989-12-15	Preparation of 5-chloro-3-chlorosulphonyl-2 thiophene-carboxylic acid esters
EP0351017A3 (en)	1990-05-30	Pharmaceutical composition useful for the treatment of cardiovascular diseases
ZA872204B (en)	1988-10-26	Etodolac for use in lowering uric acid blood levels
ATE51147T1 (de)	1990-04-15	Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
ES284303U (es)	1985-08-01	Capazo-cuna para coches-silla infantiles
JPS5382760A (en)	1978-07-21	Novel benzoylphenoxyacetic acid derivs., process for their preparation and lipid lowering agents contg. active constituents
IT8120658V0 (it)	1981-02-03	Gioco di abilita' e didattico atto a permettere la formazione di tracciati segmentati a seconda dell'abilita' e della fantasia del giocatore.
IT8019423A0 (it)	1980-01-24	11-(2'-imidazol-1''-il)-acetil-5,11-diidro-6h-pirido 2,3-b 1,4benzodiazepin-6-oni, metodo per laloro preparazione e la loro applicazione nella terapia dell'ulcera.
ES253765U (es)	1981-09-01	Parque infantil perfeccionado
ATA238087A (de)	1990-01-15	Verfahren zur herstellung von pharmazeutischen loesungen von oxazaphosphorinen mit verbesserter stabilitaet

Legal Events

Date	Code	Title	Description
1992-09-15	UEP	Publication of translation of european patent specification
2008-07-15	EELA	Cancelled due to lapse of time